Patents by Inventor Gerald A. Poore

Gerald A. Poore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-tumor method and compounds
    Patent number: 5594028
    Abstract: This invention provides certain sulfonamide derivatives, their pharmaceutical formulations, and their use in the treatment of susceptible neoplasms in mammals.
    Type: Grant
    Filed: November 21, 1994
    Date of Patent: January 14, 1997
    Assignee: Eli Lilly and Company
    Inventors: Richard W. Harper, J. Jeffry Howbert, Gerald A. Poore, Brent J. Rieder, Eddie V. P. Tao, James A. Aikins
  • Anti-tumor method and compounds
    Patent number: 5260338
    Abstract: This invention provides the use of certain benzenesulfonamide derivatives in the treatment of susceptible neoplasms in mammals. Also provided are certain novel benzenesulfonamide derivatives and their pharmaceutical formulations.
    Type: Grant
    Filed: January 28, 1992
    Date of Patent: November 9, 1993
    Assignee: Eli Lilly and Company
    Inventors: Richard W. Harper, Gerald A. Poore, Brent J. Rieder
  • Anti-tumor method and compounds
    Patent number: 5116874
    Abstract: This invention provides certain N-[(phenyl)amino]carbonyl-bicyclicsulfonamide sulfonamide derivatives, their pharmaceutical formulations, and their use in the treatment of susceptible neoplasms in mammals.
    Type: Grant
    Filed: May 15, 1989
    Date of Patent: May 26, 1992
    Assignee: Eli Lilly and Company
    Inventor: Gerald A. Poore
  • Benzenesulfonamides treatment of tumors susceptible to
    Patent number: 5110830
    Abstract: This invention provides the use of certain benzenesulfonamide derivatives in the treatment of susceptible neoplasms in mammals. Also provided are certain novel benzenesulfonamide derivatives and their pharmaceutical formulations.
    Type: Grant
    Filed: September 13, 1990
    Date of Patent: May 5, 1992
    Assignee: Eli Lilly and Company
    Inventors: Richard W. Harper, Gerald A. Poore, Brent J. Rieder
  • N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
    Patent number: 4845128
    Abstract: This invention provides the use of certain benzenesulfonamide derivatives in the treatment of susceptible neoplasms in mammals. Also provided are certain novel benzenesulfonamide derivatives and their pharmaceutical formulations.
    Type: Grant
    Filed: May 2, 1985
    Date of Patent: July 4, 1989
    Assignee: Eli Lilly and Company
    Inventors: Richard W. Harper, Gerald A. Poore, Brent J. Rieder